Evert B. Schimmelpennink's Net Worth
-$12.4 Thousand
Who is Evert B. Schimmelpennink?
Evert B. Schimmelpennink does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Pfenex Inc., and iBio, Inc..
SEC CIK
Evert B. Schimmelpennink's CIK is 0001713795
Past Insider Trading and Trends
2018 was Evert B. Schimmelpennink's most active year for acquiring shares with 4 total transactions. Evert B. Schimmelpennink's most active month to acquire stocks was the month of January. 2020 was Evert B. Schimmelpennink's most active year for disposing of shares, totalling 7 transactions. Evert B. Schimmelpennink's most active month to dispose stocks was the month of September. 2018 saw Evert B. Schimmelpennink paying a total of $50,385.00 for 232,956 shares, this is the most they've acquired in one year. In 2018 Evert B. Schimmelpennink cashed out on 11,236 shares for a total of $37,977.68, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Pfenex Inc. No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -26.66K |
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +60.03% | 10K |
$5.04 | $50,385.00 | 26.66K |
Sep 11
| |||
Form 4
|
∞
| 16.66K |
$3.38 | -$37,977.68 | 16.66K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
iBio, Inc. (IBIO) Snapshot price: $1.0985
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LENZ Therapeutics, Inc. (GRPH) No price found
President, CEO and Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Contineum Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||